Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab era
Renal involvement in patients with lymphoma is rare but associated with poor prognosis. We analyzed characteristics and outcome of 22 patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) and renal involvement treated with a rituximab-containing regimen in curative intent. The majority...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
21 Mar 2016
|
| In: |
Leukemia and lymphoma
Year: 2016, Jahrgang: 57, Heft: 11, Pages: 2619-2625 |
| ISSN: | 1029-2403 |
| DOI: | 10.3109/10428194.2016.1157869 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3109/10428194.2016.1157869
|
| Verfasserangaben: | Nicola Lehners, Isabelle Krämer, Mark-Alexander Schwarzbich, Anthony D. Ho & Mathias Witzens-Harig |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1701039729 | ||
| 003 | DE-627 | ||
| 005 | 20230426062214.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200618s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3109/10428194.2016.1157869 |2 doi | |
| 035 | |a (DE-627)1701039729 | ||
| 035 | |a (DE-599)KXP1701039729 | ||
| 035 | |a (OCoLC)1341340741 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Giesen, Nicola |d 1983- |e VerfasserIn |0 (DE-588)141844272 |0 (DE-627)631828524 |0 (DE-576)32643657X |4 aut | |
| 245 | 1 | 0 | |a Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab era |c Nicola Lehners, Isabelle Krämer, Mark-Alexander Schwarzbich, Anthony D. Ho & Mathias Witzens-Harig |
| 264 | 1 | |c 21 Mar 2016 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 18.06.2020 | ||
| 520 | |a Renal involvement in patients with lymphoma is rare but associated with poor prognosis. We analyzed characteristics and outcome of 22 patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) and renal involvement treated with a rituximab-containing regimen in curative intent. The majority of patients presented in advanced disease, 86% were Ann Arbor stage ≥ III and had an IPI score ≥ 3. Renal impairment was present in 32%. Outcome was poor with three-year progression-free survival (PFS) 44% and three-year overall survival (OS) 52% and significantly worse compared to DLBCL without renal involvement (p < 0.01). Patients with high-risk IPI had a significantly inferior prognosis compared to intermediate-risk IPI (three-year OS 0% vs. 75%, p = 0.01) as did those with renal impairment. A high rate of central nervous system (CNS) relapse (8/22) was observed. Intravenous high-dose methotrexate and intrathecal therapy showed a trend toward prolonged time to CNS relapse. Implementation of CNS prophylaxis might therefore be considered in these high-risk patients. | ||
| 650 | 4 | |a chemotherapeutic approaches | |
| 650 | 4 | |a lymphoma and Hodgkin disease | |
| 650 | 4 | |a prognostication | |
| 700 | 1 | |a Krämer, Isabelle |d 1984- |e VerfasserIn |0 (DE-588)1025613481 |0 (DE-627)723627738 |0 (DE-576)370555724 |4 aut | |
| 700 | 1 | |a Schwarzbich, Mark-Alexander |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ho, Anthony Dick |d 1948- |e VerfasserIn |0 (DE-588)108692477 |0 (DE-627)504904205 |0 (DE-576)19010466X |4 aut | |
| 700 | 1 | |a Witzens-Harig, Mathias |e VerfasserIn |0 (DE-588)1050736516 |0 (DE-627)784812322 |0 (DE-576)404988970 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia and lymphoma |d London [u.a.] : Taylor & Francis Group, 1989 |g 57(2016), 11, Seite 2619-2625 |h Online-Ressource |w (DE-627)324746237 |w (DE-600)2030637-4 |w (DE-576)099718170 |x 1029-2403 |7 nnas |a Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab era |
| 773 | 1 | 8 | |g volume:57 |g year:2016 |g number:11 |g pages:2619-2625 |g extent:7 |a Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab era |
| 856 | 4 | 0 | |u https://doi.org/10.3109/10428194.2016.1157869 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200618 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1050736516 |a Witzens-Harig, Mathias |m 1050736516:Witzens-Harig, Mathias |d 910000 |d 910100 |e 910000PW1050736516 |e 910100PW1050736516 |k 0/910000/ |k 1/910000/910100/ |p 5 |y j | ||
| 998 | |g 108692477 |a Ho, Anthony Dick |m 108692477:Ho, Anthony Dick |d 910000 |d 910100 |e 910000PH108692477 |e 910100PH108692477 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1025613481 |a Krämer, Isabelle |m 1025613481:Krämer, Isabelle |d 910000 |d 910100 |e 910000PK1025613481 |e 910100PK1025613481 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 141844272 |a Giesen, Nicola |m 141844272:Giesen, Nicola |d 910000 |d 910100 |e 910000PG141844272 |e 910100PG141844272 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1701039729 |e 3688312058 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab era","title_sort":"Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab era"}],"language":["eng"],"person":[{"display":"Giesen, Nicola","given":"Nicola","role":"aut","family":"Giesen"},{"family":"Krämer","display":"Krämer, Isabelle","given":"Isabelle","role":"aut"},{"display":"Schwarzbich, Mark-Alexander","given":"Mark-Alexander","role":"aut","family":"Schwarzbich"},{"family":"Ho","display":"Ho, Anthony Dick","role":"aut","given":"Anthony Dick"},{"given":"Mathias","role":"aut","display":"Witzens-Harig, Mathias","family":"Witzens-Harig"}],"name":{"displayForm":["Nicola Lehners, Isabelle Krämer, Mark-Alexander Schwarzbich, Anthony D. Ho & Mathias Witzens-Harig"]},"physDesc":[{"extent":"7 S."}],"id":{"eki":["1701039729"],"doi":["10.3109/10428194.2016.1157869"]},"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedKey":"1989","publisher":"Taylor & Francis Group ; Informa Healthcare","dateIssuedDisp":"1989-","publisherPlace":"London [u.a.] ; London [u.a.]"}],"recId":"324746237","id":{"eki":["324746237"],"zdb":["2030637-4"],"issn":["1029-2403"]},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab eraLeukemia and lymphoma","note":["Gesehen am 08.09.15"],"pubHistory":["1.1989/90 -"],"title":[{"title_sort":"Leukemia and lymphoma","title":"Leukemia and lymphoma"}],"language":["eng"],"part":{"pages":"2619-2625","extent":"7","issue":"11","text":"57(2016), 11, Seite 2619-2625","year":"2016","volume":"57"}}],"note":["Gesehen am 18.06.2020"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1701039729","origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"21 Mar 2016"}]} | ||
| SRT | |a GIESENNICOANALYSISOF2120 | ||